FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3127136799> ?p ?o ?g. }

• W3127136799 endingPage "685.e8" @default.
• W3127136799 startingPage "685.e1" @default.
• W3127136799 abstract "Compared with privately insured patients, recipients of Medicaid have been reported to have worse outcomes in several clinical conditions and following various surgical and medical procedures. However, the relationship between health insurance status and allogeneic hematopoietic cell transplantation (alloHCT) outcomes among patients with sickle cell disease (SCD) is not well described. We sought to compare alloHCT outcomes between patients with SCD who underwent alloHCT while enrolled on Medicaid versus those who underwent alloHCT while covered by private health insurance. We conducted a retrospective multicenter study using data reported to the Center for International Blood and Marrow Transplant Research. US patients enrolled on Medicaid or private insurance who underwent a first alloHCT for SCD between 2008 and 2018 were eligible for this study. The primary outcome was event-free survival (EFS), defined as time to death or graft failure. Secondary outcomes included overall survival (OS), graft failure, acute graft-versus-host disease (GVHD), and chronic GVHD. Univariate analysis was performed using the Kaplan-Meier method for EFS and OS. The proportion of patients with graft failure, acute GVHD, and/or chronic GVHD was calculated using the cumulative incidence estimator to accommodate competing risks (ie, death). Cox regression was used to identify factors associated with EFS, OS, graft failure, and acute and chronic GVHD. A total of 399 patients (Medicaid, n = 225; private insurance, n = 174) were included in this study. The median duration of follow-up was 34 months (range, 1.0 to 134.7 months) for the Medicaid group and 38.7 months (range, 0.3 to 139.3 months) for the private insurance group. Compared with the patients with private insurance, those on Medicaid had a significantly lower 3-year EFS (75.4% [95% confidence interval (CI), 69.4% to 81%] versus 82.2% [95% CI, 76.9% to 87.8%]; P = .0279) and a significantly higher 3-year cumulative incidence of graft failure (17.2% [95% CI, 12.5% to 22.5%] versus 10.5% [95% CI, 6.4% to 15.4%]; P = .0372). There were no significant between-group differences in 3-year OS (P = .6337) or in the cumulative incidence of acute GVHD (P = .4556) or chronic GVHD (P = .6878). Cox regression analysis after adjusting for other significant variables showed that the patients enrolled on Medicaid had a lower EFS (hazard ratio [HR], 2.36; 95% CI, 1.44 to 3.85; P = .0006) and a higher cumulative incidence of graft failure (HR, 2.57; 95% CI, 1.43 to 4.60; P = .0015), with no significant between-group differences in OS (HR, 0.99; 95% CI, 0.47 to 2.07; P = .9765), acute GVHD (HR, 0.94; 95% CI, 0.59 to 1.49; P = .7905), or cGVHD (HR, 0.98; 95% CI, 0.65 to 1.48; P = .9331). That EFS is worse in patients on Medicaid compared with privately insured individuals following alloHCT for SCD provides the rationale for research to better understand the mechanisms by which insurance status impacts alloHCT outcomes among patients with SCD." @default.
• W3127136799 created "2021-02-15" @default.
• W3127136799 creator A5018295551 @default.
• W3127136799 creator A5025790743 @default.
• W3127136799 creator A5046048880 @default.
• W3127136799 creator A5050581544 @default.
• W3127136799 creator A5056651771 @default.
• W3127136799 creator A5058862489 @default.
• W3127136799 creator A5061455564 @default.
• W3127136799 creator A5069073123 @default.
• W3127136799 creator A5081856428 @default.
• W3127136799 date "2021-08-01" @default.
• W3127136799 modified "2023-09-26" @default.
• W3127136799 title "Hematopoietic Cell Transplantation Outcomes among Medicaid and Privately Insured Patients with Sickle Cell Disease" @default.
• W3127136799 cites W1491993932 @default.
• W3127136799 cites W1517276456 @default.
• W3127136799 cites W1605115465 @default.
• W3127136799 cites W1620470969 @default.
• W3127136799 cites W1821690723 @default.
• W3127136799 cites W1961807282 @default.
• W3127136799 cites W1990856154 @default.
• W3127136799 cites W2018269551 @default.
• W3127136799 cites W2019105756 @default.
• W3127136799 cites W2033215506 @default.
• W3127136799 cites W2055416382 @default.
• W3127136799 cites W2067366670 @default.
• W3127136799 cites W2070473681 @default.
• W3127136799 cites W2071068942 @default.
• W3127136799 cites W2094461661 @default.
• W3127136799 cites W2188172476 @default.
• W3127136799 cites W2330495772 @default.
• W3127136799 cites W2414594214 @default.
• W3127136799 cites W2443703033 @default.
• W3127136799 cites W2562103559 @default.
• W3127136799 cites W2611501301 @default.
• W3127136799 cites W2745596189 @default.
• W3127136799 cites W2971545858 @default.
• W3127136799 cites W2977383596 @default.
• W3127136799 cites W3046104541 @default.
• W3127136799 cites W3094563503 @default.
• W3127136799 cites W4200424682 @default.
• W3127136799 doi "https://doi.org/10.1016/j.jtct.2021.04.009" @default.
• W3127136799 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33895405" @default.
• W3127136799 hasPublicationYear "2021" @default.
• W3127136799 type Work @default.
• W3127136799 sameAs 3127136799 @default.
• W3127136799 citedByCount "1" @default.
• W3127136799 countsByYear W31271367992022 @default.
• W3127136799 crossrefType "journal-article" @default.
• W3127136799 hasAuthorship W3127136799A5018295551 @default.
• W3127136799 hasAuthorship W3127136799A5025790743 @default.
• W3127136799 hasAuthorship W3127136799A5046048880 @default.
• W3127136799 hasAuthorship W3127136799A5050581544 @default.
• W3127136799 hasAuthorship W3127136799A5056651771 @default.
• W3127136799 hasAuthorship W3127136799A5058862489 @default.
• W3127136799 hasAuthorship W3127136799A5061455564 @default.
• W3127136799 hasAuthorship W3127136799A5069073123 @default.
• W3127136799 hasAuthorship W3127136799A5081856428 @default.
• W3127136799 hasBestOaLocation W31271367991 @default.
• W3127136799 hasConcept C10515644 @default.
• W3127136799 hasConcept C120665830 @default.
• W3127136799 hasConcept C121332964 @default.
• W3127136799 hasConcept C126322002 @default.
• W3127136799 hasConcept C144301174 @default.
• W3127136799 hasConcept C160735492 @default.
• W3127136799 hasConcept C162324750 @default.
• W3127136799 hasConcept C167135981 @default.
• W3127136799 hasConcept C2776534028 @default.
• W3127136799 hasConcept C2777408962 @default.
• W3127136799 hasConcept C2911091166 @default.
• W3127136799 hasConcept C38180746 @default.
• W3127136799 hasConcept C50382708 @default.
• W3127136799 hasConcept C50522688 @default.
• W3127136799 hasConcept C61511704 @default.
• W3127136799 hasConcept C71924100 @default.
• W3127136799 hasConceptScore W3127136799C10515644 @default.
• W3127136799 hasConceptScore W3127136799C120665830 @default.
• W3127136799 hasConceptScore W3127136799C121332964 @default.
• W3127136799 hasConceptScore W3127136799C126322002 @default.
• W3127136799 hasConceptScore W3127136799C144301174 @default.
• W3127136799 hasConceptScore W3127136799C160735492 @default.
• W3127136799 hasConceptScore W3127136799C162324750 @default.
• W3127136799 hasConceptScore W3127136799C167135981 @default.
• W3127136799 hasConceptScore W3127136799C2776534028 @default.
• W3127136799 hasConceptScore W3127136799C2777408962 @default.
• W3127136799 hasConceptScore W3127136799C2911091166 @default.
• W3127136799 hasConceptScore W3127136799C38180746 @default.
• W3127136799 hasConceptScore W3127136799C50382708 @default.
• W3127136799 hasConceptScore W3127136799C50522688 @default.
• W3127136799 hasConceptScore W3127136799C61511704 @default.
• W3127136799 hasConceptScore W3127136799C71924100 @default.
• W3127136799 hasIssue "8" @default.
• W3127136799 hasLocation W31271367991 @default.
• W3127136799 hasLocation W31271367992 @default.
• W3127136799 hasLocation W31271367993 @default.
• W3127136799 hasOpenAccess W3127136799 @default.
• W3127136799 hasPrimaryLocation W31271367991 @default.
• W3127136799 hasRelatedWork W2000208415 @default.

• next